Tetracycline compounds with non-antimicrobial organ protective properties: Possible mechanisms of action

Pharmacological Research

Volumn 63, Issue 2, 2011, Pages 102-107

  Griffin, Michael O ^a   Ceballos, Guillermo ^b,c   Villarreal, Francisco J ^b  

^a Wheaton Franciscan Healthcare   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Doxycycline; Minocycline; Protease inhibitors

Indexed keywords

COLLAGENASE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; GELATINASE; MATRIX METALLOPROTEINASE; MINOCYCLINE; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACNE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL METABOLISM; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG UPTAKE; ENCEPHALITIS; ENZYME INHIBITION; HUMAN; HUNTINGTON CHOREA; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PERIODONTITIS; PRION DISEASE; PRIORITY JOURNAL; ROSACEA; TRAUMATIC BRAIN INJURY;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHLORTETRACYCLINE; DOXYCYCLINE; HUMANS; MATRIX METALLOPROTEINASES; MINOCYCLINE; MODELS, BIOLOGICAL; OFF-LABEL USE; TETRACYCLINE;

EID: 79251631666     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.10.004     Document Type: Article

References (61)

1. B.M. Duggar Aureomycin; a product of the continuing search for new antibiotics Ann N Y Acad Sci 51 Art. 2 1948 177 181
2. N.J. Joshi, and D. Miller Doxycycline revisited Arch Intern Med 157 1997 1421 1428
3. J.H. Hash, M. Wishnick, and P.A. Miller On the mode of action of the tetracycline antibiotics in Staphylococcus aureus J Biol Chem 239 1964 2070 2078
4. T.R. Tritton Ribosome-tetracycline interactions Biochemistry 16 18 1977 4133 4138
5. Y.P. Semenkov, E.M. Makarov, V.I. Makhno, and S.V. Kirillov Kinetic aspects of tetracycline action on the acceptor (A) site of Escherichia coli ribosomes FEBS Lett 144 1 1982 125 129
6. M. Brion, L. Lambs, and G. Berthon Metal ion-tetracycline interactions in biological fluids. Part 5. Formation of zinc complexes with tetracycline and some of its derivatives and assessment of their biological significance Agents Actions 17 2 1985 229 242
7. F.R. Burns, M.S. Stack, R.D. Gray, and C.A. Paterson Inhibition of purified collagenase from alkali-burned rabbit corneas Invest Ophthalmol Vis Sci 30 7 1989 1569 1575
8. L.M. Golub, T.F. McNamara, G. D'Angelo, R.A. Greenwald, and N.S. Ramamurthy A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity J Dent Res 66 8 1987 1310 1314
9. L.M. Golub, N.S. Ramamurthy, T.F. McNamara, R.A. Greenwald, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 3 1991 297 321
10. M. Takahashi, L. Altschmied, and W. Hillen Kinetic and equilibrium characterization of the Tet repressor-tetracycline complex by fluorescence measurements. Evidence for divalent metal ion requirement and energy transfer J Mol Biol 187 3 1986 341 348
11. M.E. Ryan, A. Usman, N.S. Ramamurthy, L.M. Golub, and R.A. Greenwald Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity Curr Med Chem 8 3 2001 305 316
12. R.A. Goldman, T. Hasan, C.C. Hall, W.A. Strycharz, and B.S. Cooperman Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis Biochemistry 22 2 1983 359 368
13. M.L. Nelson Chemical and biological dynamics of tetracyclines Adv Dent Res 12 2 1998 5 11
14. G. Berthon, M. Brion, and L. Lambs Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibiotics in blood plasma J Inorg Biochem 19 1 1983 1 18
15. M. Brion, L. Lambs, and G. Berthon Metal ion-tetracycline interactions in biological fluids. Part 5. Formation of zinc complexes with tetracycline and some of its derivatives and assessment of their biological significance Agents Actions 17 2 1985 229 242
16. L. Lambs, M. Brion, and G. Berthon Metal ion-tetracycline interactions in biological fluids. Part 3. Formation of mixed-metal ternary complexes of tetracycline, oxytetracycline, doxycycline and minocycline with calcium and magnesium, and their involvement in the bioavailability of these antibiotics in blood plasma Agents Actions 14 5-6 1984 743 750
17. J.L. Colaizzi, and P.R. Klink pH-partition behavior of tetracyclines J Pharm Sci 58 10 1969 1184 1189
18. R.K. Blackwood, and A.R. English Structure-activity relationships in the tetracycline series Adv Appl Microbiol 1970 13237 13266
19. M. Barza, R.B. Brown, C. Shanks, C. Gamble, and L. Weinstein Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs Antimicrob Agents Chemother 8 6 1975 713 720
20. H. Nagase, and J.F. Woessner Matrix metalloproteinases J Biol Chem 274 31 1999 21491 21494
21. F.G. Spinale Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ Res 90 5 2002 520 530
22. M.P. d'Ortho, H. Will, S. Atkinson, G. Butler, A. Messent, and J. Gavrilovic Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases Eur J Biochem 250 3 1997 751 757
23. J.T. Peterson Matrix metalloproteinase inhibitor development and the remodeling of drug discovery Heart Fail Rev 9 1 2004 63 79
24. L.E. Rohde, A. Ducharme, L.H. Arroyo, M. Aikawa, G.H. Sukhova, and A. Lopez-Anaya Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 99 23 1999 3063 3070
25. L.M. Golub, H.M. Lee, G. Lehrer, A. Nemiroff, T.F. McNamara, and R. Kaplan Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action J Periodont Res 18 5 1983 516 526
26. G.N. Smith, E.A. Mickler, K.A. Hasty, and K.D. Brandt Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme Arthritis Rheum 42 6 1999 1140 1146
27. R.A. Greenwald, L.M. Golub, N.S. Ramamurthy, M. Chowdhury, S.A. Moak, and T. Sorsa In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation Bone 22 1 1998 33 38
28. L.M. Golub, T. Sorsa, H.M. Lee, S. Ciancio, D. Sorbi, and N.S. Ramamurthy Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva J Clin Periodontol 22 2 1995 100 109
29. T. Sorsa, Y. Ding, T. Salo, A. Lauhio, O. Teronen, and T. Ingman Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases Ann N Y Acad Sci 1994 732112 732131
30. G.N. Smith, K.D. Brandt, E.A. Mickler, and K.A. Hasty Inhibition of recombinant human neutrophil collagenase by doxycycline is pH dependent J Rheumatol 24 9 1997 1769 1773
31. R. Hanemaaijer, T. Sorsa, Y.T. Konttinen, Y. Ding, M. Sutinen, and H. Visser Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline J Biol Chem 272 50 1997 31504 31509
32. C. Jonat, F.Z. Chung, and V.M. Baragi Transcriptional downregulation of stromelysin by tetracycline J Cell Biochem 60 3 1996 341 347
33. E.E. Creemers, J.P. Cleutjens, J.F. Smits, and M.J. Daemen Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89 3 2001 201 210
34. P.E. Desrochers, K. Mookhtiar, H.E. Van Wart, K.A. Hasty, and S.J. Weiss Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases J Biol Chem 267 7 1992 5005 5012
35. J. Michaelis, M.C. Vissers, and C.C. Winterbourn Human neutrophil collagenase cleaves alpha 1-antitrypsin Biochem J 270 3 1990 809 814
36. R.J. Crout, H.M. Lee, K. Schroeder, H. Crout, N.S. Ramamurthy, and M. Wiener The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study J Periodontol 67 5 1996 506 514
37. L.M. Golub, R.T. Evans, T.F. McNamara, H.M. Lee, and N.S. Ramamurthy A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats Ann N Y Acad Sci 1994 73296 74111
38. D. Grenier, P. Plamondon, T. Sorsa, H.M. Lee, T. McNamara, and N.S. Ramamurthy Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives J Periodontol 73 1 2002 79 85
39. T. Sorsa, Y.T. Konttinen, O. Lindy, K. Suomalainen, T. Ingman, and H. Saari Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase Agents Actions Suppl 1993 39225 39229
40. T. Sorsa, O. Lindy, Y.T. Konttinen, K. Suomalainen, T. Ingman, and H. Saari Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase Antimicrob Agents Chemother 37 3 1993 592 594 (Pubitemid 23072607)
41. R.L. Kraus, R. Pasieczny, K. Lariosa-Willingham, M.S. Turner, A. Jiang, and J.W. Trauger Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity J Neurochem 94 3 2005 819 827
42. J. Yrjänheikki, R. Keinänen, M. Pellikka, T. Hökfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc Natl Acad Sci USA 95 26 1998 15769 15774
43. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, and S. Zhu Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat Med 6 7 2000 797 801
44. R.O. Sanchez Mejia, V.O. Ona, M. Li, and R.M. Friedlander Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction Neurosurgery 48 6 2001 1393 1399
45. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, and K.R. Bales Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc Natl Acad Sci USA 98 25 2001 14669 14674
46. S. Zhu, I.G. Stavrovskaya, M. Drozda, B.Y.S. Kim, V. Ona, and M. Li Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 6884 2002 74 78
47. M.T. Pelle, G.H. Crawford, and W.D. James Rosacea II theraphy J Am Acad Dermatol 51 2004 499 512
48. D. Jones Reactive oxygen species and rosacea Cutis 74 Suppl. 3 2004 17 20 32-34
49. W. Pruzanski, R.A. Greenwald, I.O. Street, F. La-leberte, E. Stefanski, and P. vadas Inhibition of enzymatic activity of phospholipase A2 by minocycline and doxycycline Biochem Pharmacol 44 1992 1165 1170
50. N.B. Esterly, J.S. Koransky, N.L. Furey, and M. Trevisan Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy Arch Dermatol 120 1984 1308 1313
51. W.L. Gabler, and N. Tsukuda The influence of divalent cations and doxycycline on iodoacetamide-inhibitable leukocyte adherence Res Commun Chem Pathol Pharmacol 74 1991 131 140
52. Y.H. Thong, and A. Ferrante Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues Clin Exp Immunol 35 1979 443 446
53. B.L. Holman Radionuclide methods in the evaluation of myocardial ischemia and infarction Circulation 53 3 Suppl. 1976 I112 I119
54. B.L. Holman, and F.G. Zweiman Time course of 99mTc(Sn)-tetracycline uptake in experimental acute myocardial infarction J Nucl Med 16 12 1975 1144 1146
55. P.J. Baker, R.T. Evans, R.A. Coburn, and R.J. Genco Tetracycline and its derivatives strongly bind to and are released from the tooth surface in active form J Periodontol 54 10 1983 580 585
56. F. Villarreal, J. Omens, W. Dillmann, J. Risteli, J. Nguyen, and J. Covell Early degradation and serum appearance of type I collagen fragments after myocardial infarction J Mol Cell Cardiol 36 4 2004 597 601
57. D. Romero-Perez, E. Fricovsky, K.G. Yamasaki, M. Griffin, M. Barraza-Hidalgo, and W. Dillmann Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection J Am Coll Cardiol 52 13 2008 1086 1094
58. Q. Yang, R.J. Nakkula, and J.D. Walters Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts J Dent Res 81 12 2002 836 840
59. M.C. Zink, J. Uhrlaub, J. DeWitt, T. Voelker, B. Bullock, and J. Mankowski Neuroprotective and anti-human immunodeficiency virus activity of minocycline JAMA 293 16 2005 2003 2011
60. G. Forloni, S. Iussich, T. Awan, L. Colombo, N. Angeretti, and L. Girola Tetracyclines affect prion infectivity Proc Natl Acad Sci USA 99 16 2002 10849 10854
61. C. Guignabert, L. Taysse, J. Calvet, E. Planus, S. Delamanche, and S. Galiacy Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs Am J Physiol Lung Cell Mol Physiol 289 1 2005 L67 74